Format

Send to

Choose Destination
See comment in PubMed Commons below
Climacteric. 2015;18(4):492-7. doi: 10.3109/13697137.2015.1034098. Epub 2015 Apr 16.

Primary prevention of cardiovascular disease with hormone replacement therapy.

Author information

  • 1Department of Cardiology, Bispebjerg Hospital , Copenhagen , Denmark.

Abstract

Many peri- and postmenopausal women suffer from a reduced quality of life due to menopausal symptoms and preventable diseases. The importance of cardiovascular disease in women must be emphasized, as it is the leading cause of mortality and morbidity in women. It is well known that female hormones contribute to the later onset of cardiovascular disease in women. The effect of estrogens has for decades been understood from observational studies of postmenopausal women treated with hormone replacement therapy (HRT). Later, treatment with HRT was disregarded due to the fear of side-effects and an ambiguity of the cardiovascular advantages. Accumulating knowledge from the large number of trials and studies has elucidated the cause for the disparity in results. In this paper, the beneficial effects of HRT, with emphasis on cardiovascular disease are explained, and the relative and absolute risks of side-effects are discussed.

KEYWORDS:

CARDIOVASCULAR; HORMONE REPLACEMENT THERAPY; PRIMARY PREVENTION

PMID:
25830825
DOI:
10.3109/13697137.2015.1034098
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center